Original Research
Accepted on 06 Sep 2024
Diacerein reduces inflammasome activation and SARS-CoV-2 virus replication: a proof-of-concept translational study
in Translational Pharmacology
Original Research
Accepted on 06 Sep 2024
in Translational Pharmacology
Review
Accepted on 06 Sep 2024
in Intestinal Microbiome
Original Research
Accepted on 06 Sep 2024
in Inflammation Pharmacology
Original Research
Accepted on 06 Sep 2024
in Genomics of Plants and the Phytoecosystem
Original Research
Accepted on 06 Sep 2024
in Computational Genomics
Mini Review
Accepted on 06 Sep 2024
in Parasite Immunology
Original Research
Accepted on 06 Sep 2024
in Toxicology, Pollution and the Environment
Original Research
Accepted on 06 Sep 2024
in Toxicology, Pollution and the Environment
Opinion
Accepted on 06 Sep 2024
in Advanced Methods in Pharmacovigilance and Pharmacoepidemiology
Original Research
Accepted on 06 Sep 2024
in Neuro-Oncology and Neurosurgical Oncology
Original Research
Accepted on 06 Sep 2024
in Neurorehabilitation
Case Report
Accepted on 06 Sep 2024
in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Case Report
Accepted on 06 Sep 2024
in Gynecological Oncology
Editorial
Accepted on 06 Sep 2024
in Breast Cancer
Original Research
Accepted on 06 Sep 2024
in Animal Nutrition
Review
Accepted on 06 Sep 2024
in Experimental Pharmacology and Drug Discovery